Phocas Financial Corp. Exact Sciences Corp Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	BUY	$30.35 - $53.15 $45,525 - $79,725	1,500 New	1,500 $0
Q3 2019 Nov 15, 2019	SELL	$90.37 - $122.49 $135,555 - $183,735	-1,500 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$89.51 - $118.04 $134,265 - $177,060	1,500 New	1,500 $0
Q1 2019 May 13, 2019	SELL	$61.98 - $96.5 $92,970 - $144,750	-1,500 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$56.04 - $82.66 $84,060 - $123,990	1,500 New	1,500 $95,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.